PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Federal University of São Carlos (UFSCar), São Carlos, Brazil; Biotechnology Graduate Program, Federal University of São Carlos (UFSCar), São Carlos, Brazil.\', \'Department of Medicine, Federal University of São Carlos (UFSCar), São Carlos, Brazil. Electronic address: henriquepott@ufscar.br.\', \'Department of Chemistry, Federal University of São Carlos (UFSCar), São Carlos, Brazil.\', \'Department of Gerontology, Federal University of São Carlos (UFSCar), São Carlos, Brazil.\', \'Biotechnology Graduate Program, Federal University of São Carlos (UFSCar), São Carlos, Brazil; Department of Biological Sciences Parasitology, Federal University of São Carlos (UFSCar), São Carlos, Brazil.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1567-5769(21)00949-810.1016/j.intimp.2021.108313
?:doi
?:hasPublicationType
?:journal
  • International immunopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34741868
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.051
?:rankingScore_hIndex
  • 94
is ?:relation_isRelatedTo_publication of
?:title
  • Phenylalanine and COVID-19: Tracking disease severity markers.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all